{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:19:06Z","timestamp":1792592346503,"version":"4.5.0"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>The global rise in pediatric obesity has paralleled an alarming increase in metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). MASLD in children represents a significant public health concern due to its potential progression to advanced liver disease and its association with a myriad of cardiometabolic comorbidities. This review elucidates the risk and consequences of pediatric MASLD in the population of children with obesity. It also identifies critical research gaps and outlines future directions for the prevention, diagnosis, and treatment of pediatric MASLD.<\/jats:p>","DOI":"10.3389\/fped.2025.1675713","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T06:25:50Z","timestamp":1761632750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The evolving landscape of pediatric obesity and metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Resthie R.","family":"Putri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"B1","article-title":"World Obesity Atlas 2024","author":"Lobstein","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2021053708","DOI":"10.1542\/peds.2021-053708","article-title":"Changes in the incidence of childhood obesity","volume":"150","author":"Cunningham","year":"2022","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000521913","article-title":"The global spread of severe obesity in toddlers, children, and adolescents: a systematic review and meta-analysis","volume":"15","author":"Pinhas-Hamiel","year":"2022","journal-title":"Obes Facts"},{"key":"B4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000\u20132021","volume":"56","author":"Li","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2020-0771","article-title":"Incidence of nonalcoholic fatty liver disease in children: 2009\u20132018","volume":"146","author":"Sahota","year":"2020","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jpeds.2005.07.020","article-title":"Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists","volume":"147","author":"Riley","year":"2005","journal-title":"J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.numecd.2010.05.003","article-title":"Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children","volume":"22","author":"Bedogni","year":"2012","journal-title":"Nutr, Metab Cardiovasc Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijpo.12601","article-title":"Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. analysis of the APV initiative","volume":"15","author":"Koutny","year":"2020","journal-title":"Pediatr Obes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.107.739920","article-title":"Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease","volume":"118","author":"Schwimmer","year":"2008","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12887-017-0867-z","article-title":"Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity","volume":"17","author":"Jimenez-Rivera","year":"2017","journal-title":"BMC Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12887-019-1711-4","article-title":"Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German\/Austrian\/Swiss obesity registry APV","volume":"19","author":"Greber-Platzer","year":"2019","journal-title":"BMC Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.2337\/dc07-0281","article-title":"Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children","volume":"30","author":"Nobili","year":"2007","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpeds.2017.03.007","article-title":"Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children","volume":"187","author":"Newton","year":"2017","journal-title":"J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/nejmoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.cgh.2018.11.033","article-title":"Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jhep.2019.06.023","article-title":"Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease","volume":"71","author":"Nobili","year":"2019","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jpeds.2018.02.038","article-title":"Clinically actionable hypercholesterolemia and hypertriglyceridemia in children with nonalcoholic fatty liver disease","volume":"198","author":"Harlow","year":"2018","journal-title":"J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jpeds.2013.10.071","article-title":"Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels","volume":"164","author":"Molleston","year":"2014","journal-title":"J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1210\/clinem\/dgaa753","article-title":"Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood","volume":"106","author":"Bardugo","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12916-019-1449-8","article-title":"The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action","volume":"17","author":"Di Cesare","year":"2019","journal-title":"BMC Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000500436","article-title":"Prevalence of severe obesity among primary school children in 21 European countries","volume":"12","author":"Spinelli","year":"2019","journal-title":"Obes Facts"},{"key":"B26","article-title":"Obesity and overweight.","year":"2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S2213-8587(21)00145-5","article-title":"European Commission classifies obesity as a chronic disease","volume":"9","author":"Burki","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/obr.12551","article-title":"Obesity: a chronic relapsing progressive disease process. A position statement of the world obesity federation","volume":"18","author":"Bray","year":"2017","journal-title":"Obes Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2213-8587(23)00058-X","article-title":"Lancet diabetes & endocrinology commission on the definition and diagnosis of clinical obesity","volume":"11","author":"Rubino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e20193666","DOI":"10.1542\/peds.2019-3666","article-title":"Body mass index from early to late childhood and cardiometabolic measurements at 11 to 12 years","volume":"146","author":"Lycett","year":"2020","journal-title":"Pediatrics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","article-title":"Obesity in children and adolescents: epidemiology, causes, assessment, and management","volume":"10","author":"Jebeile","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41572-023-00435-4","article-title":"Child and adolescent obesity","volume":"9","author":"Lister","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"B34","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/joim.13547","article-title":"Pediatric obesity\u2014long-term consequences and effect of weight loss","volume":"292","author":"Marcus","year":"2022","journal-title":"J Intern Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7570\/jomes24013","article-title":"Understanding adipose tissue dysfunction","volume":"33","author":"Bl\u00fcher","year":"2024","journal-title":"J Obes Metab Syndr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/DMSO.S432344","article-title":"The characteristics, mechanisms and therapeutics: exploring the role of gut microbiota in obesity","volume":"16","author":"Zhuang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1079\/phn2005799","article-title":"Laboratory and field measurements of body composition","volume":"8","author":"Norgan","year":"2005","journal-title":"Public Health Nutr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/obr.12462","article-title":"Simple tests for the diagnosis of childhood obesity: a systematic review and meta-analysis","volume":"17","author":"Simmonds","year":"2016","journal-title":"Obes Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ypmed.2016.02.035","article-title":"Assessment of adolescent weight status: similarities and differences between CDC, IOTF, and WHO references","volume":"87","author":"Li","year":"2016","journal-title":"Prev Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2147\/CLEP.S375981","article-title":"Differences in classification standards for the prevalence of overweight and obesity in children. A systematic review and meta-analysis","volume":"14","author":"Llorca-Colomer","year":"2022","journal-title":"Clin Epidemiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.2047-6310.2012.00064.x","article-title":"Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity","volume":"7","author":"Cole","year":"2012","journal-title":"Pediatr Obes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","article-title":"WHO Child growth standards based on length\/height, weight and age","volume":"450","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"B43","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"De Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"B44","first-page":"1","article-title":"2000 CDC Growth charts for the United States: methods and development","volume":"11","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"key":"B45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/apa.14113","article-title":"Severe obesity is a limitation for the use of body mass index standard deviation scores in children and adolescents","volume":"107","author":"J\u00fal\u00edusson","year":"2018","journal-title":"Acta Paediatr"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijpo.13161","article-title":"Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: proceedings of expert roundtable meetings","volume":"19","author":"Kelly","year":"2024","journal-title":"Pediatr Obes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/obr.12904","article-title":"A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years","volume":"20","author":"Sharma","year":"2019","journal-title":"Obes Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1542\/peds.2022-060641","article-title":"Executive summary: clinical practice guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"key":"B49","article-title":"Nationellt V\u00e5rdprogram F\u00f6r Behandling Av Obesitas Hos Barn Och Ungdomar","year":"2023"},{"key":"B50","article-title":"Nationella Riktlinjer F\u00f6r V\u00e5rd Och St\u00f6d Vid Adhd Och Autism\u2014Prioriteringsst\u00f6d till Beslutsfattare Och Chefer 2022","year":"2022"},{"key":"B51","article-title":"Obesity\u202f: identification, assessment and management","year":"2014"},{"key":"B52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000368963","article-title":"Predicting weight loss and maintenance in overweight\/obese pediatric patients","volume":"82","author":"Wiegand","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2016-1885","article-title":"Which amount of BMI-SDS reduction is necessary to improve cardiovascular risk factors in overweight children?","volume":"101","author":"Reinehr","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/adc.2009.165340","article-title":"What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health?","volume":"95","author":"Ford","year":"2010","journal-title":"Arch Dis Child"},{"key":"B55","article-title":"BORIS Annual Report","year":"2022"},{"key":"B56","doi-asserted-by":"publisher","first-page":"CD012651","DOI":"10.1002\/14651858.CD012651","article-title":"Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years","volume":"2017","author":"Mead","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B57","article-title":"Wegovy (semaglutide)","year":""},{"key":"B58","article-title":"Saxenda (liraglutide)","year":""},{"key":"B59","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/nejmoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/nejmoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B62","article-title":"A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity, or Are Overweight With Weight-Related Comorbidities","year":"2023"},{"key":"B63","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MPG.0000000000000715","article-title":"Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN hepatology committee position statement","volume":"60","author":"Nobili","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B64","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S2213-8587(16)30424-7","article-title":"Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study","volume":"5","author":"Olbers","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cld.1027","article-title":"Epidemiology of pediatric nonalcoholic fatty liver disease","volume":"17","author":"Yu","year":"2021","journal-title":"Clin Liver Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J Hepatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1053\/j.gastro.2005.05.041","article-title":"Natural history of NAFLD: remarkably benign in the absence of cirrhosis","volume":"129","author":"Day","year":"2005","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"100685","DOI":"10.1016\/j.jhepr.2023.100685","article-title":"A natural history study of paediatric non-alcoholic fatty liver disease over 10 years","volume":"5","author":"Draijer","year":"2023","journal-title":"JHEP Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1572-0241.1983.tb01898.x","article-title":"Steatohepatitis in obese children: a cause of chronic liver dysfunction","volume":"78","author":"Moran","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/jpn3.12156","article-title":"Paediatric steatotic liver disease has unique characteristics: a multisociety statement endorsing the new nomenclature","volume":"78","author":"Baumann","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/children10030560","article-title":"Comparison of MAFLD and NAFLD characteristics in children","volume":"10","author":"Xing","year":"2023","journal-title":"Children"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.jhep.2024.01.004","article-title":"Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD\u2014identifying the optimal pediatric label","volume":"80","author":"Wang","year":"2024","journal-title":"J Hepatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% Of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/17474124.2019.1595589","article-title":"Pediatric NAFLD: an overview and recent developments in diagnostics and treatment","volume":"13","author":"Draijer","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1067\/S0022-3476(03)00325-1","article-title":"Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease","volume":"143","author":"Schwimmer","year":"2003","journal-title":"J Pediatr"},{"key":"B81","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/MPG.0000000000003578","article-title":"Macronutrient and micronutrient intake in adolescents with non-alcoholic fatty liver disease","volume":"75","author":"Porto","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1039\/d3fo00882g","article-title":"Meta-analysis of the association between major foods with added fructose and non-alcoholic fatty liver disease","volume":"14","author":"Liu","year":"2023","journal-title":"Food Funct"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.cgh.2021.11.026","article-title":"Systematic review and meta-analysis: the role of diet in the development of nonalcoholic fatty liver disease","volume":"21","author":"Tsompanaki","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10654-020-00627-2","article-title":"Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population","volume":"35","author":"Alferink","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/1471-0528.16199","article-title":"Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study","volume":"127","author":"Cantoral","year":"2020","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijpo.12615","article-title":"Effect of the patatin-like phospholipase domain containing 3 gene (PNPLA3) I148M polymorphism on the risk and severity of nonalcoholic fatty liver disease and metabolic syndromes: a meta-analysis of paediatric and adolescent individuals","volume":"15","author":"Li","year":"2020","journal-title":"Pediatr Obes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/ajg.2017.140","article-title":"Low birthweight increases the likelihood of severe steatosis in pediatric non-alcoholic fatty liver disease","volume":"112","author":"Bugianesi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MPG.0000000000000632","article-title":"Liver biopsy in children: position paper of the ESPGHAN hepatology committee","volume":"60","author":"Dezs\u0151fi","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J Hepatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity\u2014assessment, treatment, and prevention: an endocrine society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American association for the study of liver diseases (AASLD)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3748\/wjg.v19.i18.2740","article-title":"Persistent hypertransaminasemia in asymptomatic children: a stepwise approach","volume":"19","author":"Vajro","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B94","article-title":"Utredning Och Handl\u00e4ggning Av Fettleversjukdom Hos Barn Och Ungdomar Med \u00d6vervikt Och Fetma","year":"2021"},{"key":"B95","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/oby.20173","article-title":"Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children","volume":"21","author":"Koot","year":"2013","journal-title":"Obesity"},{"key":"B96","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpeds.2016.03.021","article-title":"Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients","volume":"173","author":"Desai","year":"2016","journal-title":"J Pediatr"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2021.784221","article-title":"Magnetic resonance imaging-proton density fat fraction vs. Transient elastography-controlled attenuation parameter in diagnosing non-alcoholic fatty liver disease in children and adolescents: a meta-analysis of diagnostic accuracy","volume":"9","author":"Jia","year":"2022","journal-title":"Front Pediatr"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1080\/17474124.2020.1801413","article-title":"Noninvasive diagnostic tools for pediatric NAFLD: where are we now?","volume":"14","author":"Mosca","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e5832","DOI":"10.1097\/MD.0000000000005832","article-title":"Liver steatosis in children with chronic hepatitis B and C: prevalence, predictors, and impact on disease progression","volume":"96","author":"Pokorska-\u015apiewak","year":"2017","journal-title":"Medicine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12072-019-09948-1","article-title":"Biliary features in liver histology of children with autoimmune liver disease","volume":"13","author":"Di Giorgio","year":"2019","journal-title":"Hepatol Int"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1013266","DOI":"10.3389\/fgene.2022.1013266","article-title":"Lysosomal acid lipase deficiency: a rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease","volume":"13","author":"Besler","year":"2022","journal-title":"Front Genet"},{"key":"B102","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.jhepr.2023.100915","article-title":"Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD","volume":"6","author":"Akbari","year":"2024","journal-title":"JHEP Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/MEG.0000000000002299","article-title":"Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis","volume":"34","author":"Ciardullo","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cgh.2022.05.028","article-title":"Incidence of type 2 diabetes in children with nonalcoholic fatty liver disease","volume":"21","author":"Newton","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/jcm8060868","article-title":"A systematic review of NAFLD-associated extrahepatic disorders in youths","volume":"8","author":"Pacifico","year":"2019","journal-title":"J Clin Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/hep.21262","article-title":"NAFLD In children: a prospective clinical-pathological study and effect of lifestyle advice","volume":"44","author":"Nobili","year":"2006","journal-title":"Hepatology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/adc.2008.143594","article-title":"Lifestyle intervention in obese children with nonalcoholic fatty liver disease: 2-year follow-up study","volume":"94","author":"Reinehr","year":"2009","journal-title":"Arch Dis Child"},{"key":"B112","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/nejmoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/nejmoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B115","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12887-021-02747-4","article-title":"Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity\u2014a nationwide cross-sectional cohort study","volume":"21","author":"Putri","year":"2021","journal-title":"BMC Pediatr"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1004165","article-title":"The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: a retrospective two-cohort study","volume":"20","author":"Prinz","year":"2023","journal-title":"PLoS Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"101425","DOI":"10.1016\/j.jhepr.2025.101425","article-title":"The association between childhood obesity and major adverse liver outcomes in adolescence and young adulthood","volume":"7","author":"Putri","year":"2025","journal-title":"JHEP Rep"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2337\/dc22-2048","article-title":"High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated alt, using a low threshold","volume":"46","author":"Castera","year":"2023","journal-title":"Diabetes Care"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1542\/peds.2012-1176","article-title":"Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis","volume":"130","author":"Ho","year":"2012","journal-title":"Pediatrics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e12502","DOI":"10.1111\/cob.12502","article-title":"Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: a nationwide nested case\u2013control study","volume":"12","author":"Putri","year":"2022","journal-title":"Clin Obes"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1675713\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T06:25:51Z","timestamp":1761632751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1675713\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":120,"alternative-id":["10.3389\/fped.2025.1675713"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1675713","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"article-number":"1675713"}}